european medicines agency glp-1 vision loss recommendation november 2025 Warning over Ozempic, drugs for potential GLP-1 Agonists Weight Loss Drugs

It's important to remember, however, that these benefits arise when GLP-1s are used under medical supervision as part of a comprehensive plan tailored to your individual needs

Emanuel, Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity

For example, even though the patent expiry in India has been reported to possibly drive prices down below US$50 a month at an estimated INR4,000 (US$44.36) or so monthly, this means little in a market where the average salaried female worker only earns INR16,671 (US$184.86) and the average salaried male worker earns INR22,520 (US$249.72) a month, according to National Statistics Office data

Department of Health and Human Services (HHS)

Blanks were acquired after each triplicate measure